Promising Neuroimaging Biomarkers for Multiple Sclerosis: David Li, MD, FRCPC
October 27th 2021The director of the Multiple Sclerosis/MRI Research Group at the University of British Columbia spoke to some of the newer biomarkers and measures being assessed in the clinical management of multiple sclerosis. [WATCH TIME: 3 minutes]
Multiple Sclerosis MRI Protocol Card: David Li, MD, FRCPC
October 26th 2021The director of the Multiple Sclerosis/MRI Research Group at the University of British Columbia spoke to the portable Standardized MRI Protocol card that is being distributed in an effort to better inform the community to follow the newly published guidelines. [WATCH TIME: 2 minutes]
Induction vs Escalation for MS: Should Patients Be Started on High-Efficacy DMT?
October 26th 2021In the presidential lecture series at CMSC 2021, Ellen M. Mowry, MD, called into question whether or not the induction treatment approach in multiple sclerosis does in fact present a higher chance of preventing long-term disability.
Multiple Sclerosis Care During a Pandemic
June 17th 2021Join Ahmed Obeidat, MD, PhD; Anne Cross, MD; and Gloria von Geldern, MD, for the third program in this series, where they offer insight from neurology specialists on applying lessons learned from the COVID-19 pandemic into clinical practice when managing patients with multiple sclerosis.
MRI in Multiple Sclerosis Guidelines Update: North America, Europe Align on New Recommendations
June 15th 2021These consensus guidelines are significant not only for their key updates to clinical practice but for their representation of a more unified, global approach to diagnosing and monitoring patients with multiple sclerosis.